Skip to main content
Medicine logoLink to Medicine
. 2023 Mar 24;102(12):e33289. doi: 10.1097/MD.0000000000033289

Case report: Mild leukoencephalopathy caused by a new mutation of NOTCH3 gene

Yuxiang Qi a, Hairong Li a, Ling Yu a,*
PMCID: PMC10035987  PMID: 36961171

Background:

Cerebral autosomal dominant arteriosis with subcortical infarction and leukoencephalopathy (CADASIL) is a single-gene small-vessel disease of the brain characterized by migraine, recurrent ischemic stroke, psychiatric disorders, progressive cognitive decline, and occasional intracerebral hemorrhage.[1] NOTCH3 was identified as a pathogenic gene for CADASIL.[2] The NOTCH3 gene encodes a membrane-bound receptor protein, and to date, several different NOTCH3 gene mutations have been identified.[3] Here, we report a case of CADASIL with a heterozygous mutation c.931T > G (thymine > guanine) on the exon region of the NOTCH3 gene, resulting in an amino acid change p.C311G (cysteine > glycine).

Case report:

We report a case of a female patient with CADASIL whose genetic sequencing revealed a mutation in the NOTCH3 gene. However, this patient did not exhibit any of the typical clinical findings of CADASIL but the patient’s cerebral magnetic resonance imaging was consistent with the characteristic findings of CADASIL.

Conclusions:

This case reminds us that mutations caused by different mutation sites present different clinical symptoms.

Keywords: CADASIL, gene mutation, leukoencephalopathy, NOTCH3

1. Introduction

NOTCH3 gene mutation is associated with cerebral autosomal dominant arteriosis with subcortical infarction and leukoencephalopathy (CADASIL).[4] NOTCH3 gene is mainly expressed in smooth muscle cells of arterial vessels.[5] NOTCH3 protein belongs to NOTCH3 receptor family, which extracellular region contains 34 epidermal growth factor like (EGF-like) repeats. Each EGF-like repeat is approximately 40 amino acids in length and contains 6 cysteine residues, which are pairwise bound by 3 disulfide bonds and play an important role in maintaining protein stability.[6] CADASIL is the most familiar genetic disease caused by NOTCH3 gene mutation. CADASIL mainly affects young and middle-aged people, with recurrent subcortical ischemic stroke, migraine, cognitive and affective disorders, and epilepsy as the main clinical manifestations.[7] CADASIL can be disagnosed by the presence of mutations on 23 exons of NOTCH3 gene or deposition of GOM or NOTCH protein in arteriolar smooth muscle.[8]

2. Case report

A 47-year-old female patient was treated in the Dermatology Department of Shengli Oilfield Central Hospital in December 2020 due to neck herpes zoster. The patient is a professional and technical worker with a junior college education level. She used to be healthy and she is an only child in her family. Diagnosis on admission showed that there were several clusters of miliary to soy-sized cuticular herpes in the skin of the patient’s right lateral neck but there is no herpes in the right external auditory canal. Herpes content is clear, without pus and blood, and the boundary is relatively clear. The rash was banded along the unilateral nerve distribution area.

During hospitalization, the patient presented with right occipital pain. In order to clarify the cause, intracranial organic lesions were excluded, and improving cerebral magnetic resonance imaging (MRI) examination. MRI examination results are shown in Figure 1. Carefully inquire about her medical history, the results are as follows: The patient has a history of neurodermatitis for several years, and the condition is stable; The patient has no history of migraine, acute cerebrovascular disease and epilepsy; The patient has no history of CO poisoning and exposure to toxic substances such as heavy metals, benzene and organophosphorus pesticides; Both parents of the patient are healthy without a family history of hereditary diseases. In addition, the patient’s neurological examination showed no obvious positive signs. Improving the mini-mental state examination score = 29 and improving the Montreal cognitive assessment score = 28. Improving inspection of laboratory indexes, including antinuclear antibody spectrum, antivasculitis antibody spectrum, 4 items before operation (AIDS, syphilis, hepatitis B virus, hepatitis C virus), thyroid function and thyroid antibody, serum vitamin B12 level, folic acid level, serum immunoglobulin, complement, liver and kidney function, blood glucose, blood lipids and so on. No significant abnormalities were observed in the above indexes.

Figure 1.

Figure 1.

Cerebral MRI images of the patient’s brain. MRI = magnetic resonance imaging.

Further ask if any close relatives of the patient had undergone cerebral imaging examination. It was found that her mother had suffered from trauma months ago and had undergone cerebral MRI examination. The MRI examination results as show in Figure 2. Cerebral MRI of the patient’s mother showed bilateral symmetrical white matter lesions of the anteroposterior and posteroposterior side of the lateral ventricles and the parabody of the lateral ventricles, which were connected into slices. The patient’s mother had the same pattern of white matter lesions as the patient, but the degree of lesions is heavier than that of patients. Therefore, we speculated that the patient had a high possibility of hereditary white matter lesions. Table 1 shows the results of further genetic testing of patient. Figure 3 shows that the patient with a heterozygous mutation c.931T > G (thymine > guanine), resulting in the change of amino acid p.C311G (cysteine > glycine).

Figure 2.

Figure 2.

Cerebral MRI image of the patient’s mother’s brain. MRI = magnetic resonance imaging.

Table 1.

Results of further genetic testing of patient.

Gene NOTCH3 MTHFR
Variable site c.931T > G chr19-15302340 p.C311G c.665C > T chr1-11856378 p.A222V
Zygote Heterozygosis 135/176 0.57 Isozygoty 0/401 1.00
Carrying rate of normal population - 0.3085568
Transcription version gene subregion NM_000435.2 exon6 NM_005957.4 exon5
Family validation - -
ACMG variant rating Pathogenic VUS
Disease information 1. Cerebral arteriosis with subcortical infarction and leukoencephalopathy type 1 (AD); 2. Lateral meningocele syndrome (AD); 3. Myofibromatosis in infants type 2 (AD) 1. MTHFR-deficient homocysteinuria (AR)

Figure 3.

Figure 3.

Genetic test results of the patient.

3. Discussion

The patient had a heterozygous missense mutation on exon 6 of NOTCH3 gene, which resulted in amino acid changes p.C311G (Cysteine > Glycine) in our study. According to ACMG guidelines, this variation can be rated as pathogenic.[9] However, HGMDpro database has not been reported until now. The patient did not show any typical clinical manifestations of CADASIL, and patient’s mother only showed mild cognitive dysfunction, with no obvious restriction on her daily life. However, MRI of the brain of the patient and her mother conformed to the characteristics of CADASIL. Compared with classical CADASIL, the mutation caused by this mutation site shows relatively mild CADASIL clinical symptoms.

NOTCH3 gene mainly encodes highly conserved transmembrane receptors and participates in specific cell death during embryonic development. The gene contains 33 exons and encodes a 2321 amino acid transmembrane receptor. Its extracellular domain contains 34 EGF-like repeats, which are encoded by exons from 2 to 23.[10] The study showed that CADASIL-related mutations were mainly distributed in these 34 EGF-like repeats.[11] Wang et al[12] report that in 33 CADASIL Chinese families, 85% of the mutations were located on exons 3 or 4, and the rest were located on exons 2, 11 or 20, in addition, some researchers reported cases of CADASIL caused by mutations on exon 6.

Gene mutation causes the increase or decrease of cysteine residues in EGFR, which makes the number of cysteine residues become singular, thus destroying the structure of disulfide bond.[13] That NOTCH3 protein, encoded by the mutated gene, forms extracellular aggregates and deposits in smooth muscle cells in the walls of small arteries, including brain, kidney, spleen, heart muscle, muscle, and cerebral arterioles.[14] This phenomenon can lead to subcortical infarction and diffuse white matter hyperintensity, and white matter lesions in the temporal lobe or external capsule are characteristic for the diagnosis of CADASIL disease.[15,16] Mutations not only affect the formation of disulfide bonds in the EGFR region and destroy the stability of the extracellular segment of the transmembrane protein,[17] but also affect the intracellular signal transduction of NOTCH3 protein.[18] Therefore, mutations at different NOTCH3 gene loci can lead to different clinical symptoms.

4. Conclusion

This case suggests that NOTCH3 gene mutation shows different clinical symptoms due to different mutation sites, which may be related to different effects of different mutation sites on NOTCH3 protein intracellular signal transduction. In this study, this patient had the typical imaging findings of CADASIL (structural changes) but not the typical clinical findings of CADASIL (functional findings). Therefore, further study on the changes of different signal transduction pathways caused by NOTCH3 gene mutation will help to better understand CADASIL and seek clinical treatment methods.

Author contributions

Data curation: Yuxiang Qi.

Formal analysis: Hairong Li.

Methodology: Hairong Li.

Investigation: Ling Yu.

Writing – original draft: Yuxiang Qi, Ling Yu.

Writing – review & editing: Yuxiang Qi, Ling Yu.

Abbreviations:

CADASIL
arteriosis with subcortical infarction and leukoencephalopathy
EGF-like
epidermal growth factor like
MRI
magnetic resonance imaging

The experimental procedures were all in accordance with the guideline of the Ethics Committee of Shengli Oilfield Central Hospital, and has approved by the Ethics Committee of Shengli Oilfield Central Hospital. This study complies with the Declaration of Helsinki.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

The authors have no funding and conflicts of interest to disclose.

How to cite this article: Qi Y, Li H, Yu L. Case report: Mild leukoencephalopathy caused by a new mutation of NOTCH3 gene. Medicine 2023;102:12(e33289).

Contributor Information

Yuxiang Qi, Email: yu5bnk@163.com.

Hairong Li, Email: zhang78509535@163.com.

References

  • [1].Hu L, Liu G, Fan Y. R558C NOTCH3 mutation in a CADASIL patient with intracerebral hemorrhage: a case report with literature review. J Stroke Cerebrovasc Dis. 2022;31:106541. [DOI] [PubMed] [Google Scholar]
  • [2].Ni W, Zhang Y, Zhang L, et al. Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations. CNS Neurosci Ther. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Almeida MR, Elias I, Fernandes C, et al. NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype. Neurogenetics. 2022;23:1–9. [DOI] [PubMed] [Google Scholar]
  • [4].Schoemaker D, Arboleda-Velasquez JF. NOTCH3 signaling and aggregation as targets for the treatment of CADASIL and other NOTCH3-associated small-vessel diseases. Am J Pathol. 2021;191:1856–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Wang Y, Dai S, Cheng X, et al. NOTCH3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension. Nutr Metab Cardiovasc Dis. 2019;29:639–51. [DOI] [PubMed] [Google Scholar]
  • [6].Machowska-Sempruch K, Bajer-Czajkowska A, Makarewicz K, et al. A novel NOTCH3 gene mutation in a polish CADASIL family. J Stroke Cerebrovasc Dis. 2019;28:574–6. [DOI] [PubMed] [Google Scholar]
  • [7].Manini A, Pantoni L. CADASIL from bench to bedside: disease models and novel therapeutic approaches. Mol Neurobiol. 2021;58:2558–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain. 2009;132(Pt 4):933–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Brandt T, Sack LM, Arjona D, et al. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants. Genet Med. 2020;22:336–44. [DOI] [PubMed] [Google Scholar]
  • [10].Hosseini-Alghaderi S, Baron M. NOTCH3 in development, health and disease. Biomolecules. 2020;10:485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Hu Y, Sun Q, Zhou Y, et al. NOTCH3 variants and genotype-phenotype features in Chinese CADASIL patients. Front Genet. 2021;12:705284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Wang Z, Yuan Y, Zhang W, et al. NOTCH3 mutations and clinical features in 33 mainland Chinese families with CADASIL. J Neurol Neurosurg Psychiatry. 2011;82:534–9. [DOI] [PubMed] [Google Scholar]
  • [13].Wang W, Ren Z, Shi Y, et al. A novel mutation outside of the EGFr encoding exons of NOTCH3 gene in a Chinese with CADASIL. J Stroke Cerebrovasc Dis. 2020;29:105410. [DOI] [PubMed] [Google Scholar]
  • [14].Henshall TL, Keller A, He L, et al. NOTCH3 is necessary for blood vessel integrity in the central nervous system. Arterioscler Thromb Vasc Biol. 2015;35:409–20. [DOI] [PubMed] [Google Scholar]
  • [15].Tatum WO. Mesial temporal lobe epilepsy. J Clin Neurophysiol. 2012;29:356–65. [DOI] [PubMed] [Google Scholar]
  • [16].O’Sullivan M, Jarosz JM, Martin RJ, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628–34. [DOI] [PubMed] [Google Scholar]
  • [17].Young KZ, Lee SJ, Zhang X, et al. NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease. J Biol Chem. 2020;295:1960–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Bellavia D, Checquolo S, Palermo R, et al. The NOTCH3 receptor and its intracellular signaling-dependent oncogenic mechanisms. Adv Exp Med Biol. 2018;1066:205–22. [DOI] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES